Skip to main content Accessibility help
×
×
Home
  • Print publication year: 2013
  • Online publication date: April 2013

Section 3. - Psychiatric illnesses

Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

Behavioral Emergencies for the Emergency Physician
  • Online ISBN: 9781139088077
  • Book DOI: https://doi.org/10.1017/CBO9781139088077
Please enter your name
Please enter a valid email address
Who would you like to send this to *
×

References

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision. Washington, DC: The American Psychiatric Association; 2000.
2. BoudreauxED, ClarkS, CamargoCA Jr.Mood disorder screening among adult emergency department patients: a multicenter study of prevalence, associations and interest in treatment. Gen Hosp Psychiatry 2008;30:4.
3. AkiskalHS. Mood disorders: clinical features. In: SadockBJS, SadockVA, RuizP, (Eds.). Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, (9th Edition). Philadelphia, PA: Lippincott Williams and Wilkins; 2009: 1679.
4. CruzDD, PearsonA, SainiP, et al. Emergency department contact prior to suicide in mental health patients. Emerg Med J 2011;28:467–71.
5. PearnJ, Gardner-ThorpeC. Jules Cotard (1840–1889): his life and the unique syndrome which bears his name. Neurology 2002;58:1400–3.
6. VinkD, AartsenMJ, SchoeversRA. Risk factors for anxiety and depression in the elderly: a review. J Affect Disord 2008;106:29–44.
7. EdwardsCD, GlickR. Depression. In: GlickR, BerlinJS, FishkindAB, ZellerSL, (Eds.). Emergency Psychiatry: Principles and Practice. Philadelphia: Lippincott Williams and Wilkins; 2008: 175–87.
8. CharneyDS, ReynoldsCF, LewisL, et al. Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry 2003;60:664–72.
9. SadockBJS, SadockVA. Geriatric psychiatry. Kaplan & Sadock’s Synopsis of Psychiatry, (10th Edition). Philadelphia: Lippincott Williams & Williams; 2008: 1348–58.
10. SadockBJS, SadockVA. Mood disorders and suicide in children and adolescents. Kaplan & Sadock’s Synopsis of Psychiatry, (10th Edition). Philadelphia: Lippincott Williams & Williams; 2008: 1258–69.
11. BhatiaSK, BhatiaSC. Childhood and adolescent depression. Am Fam Physician 2007;75:73–80.
12. AACAP Official Action. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 2007;46:1503–26.
13. PearlsteinT, HowardM, SalisburyA, ZlotniickC. Postpartum depression. Am J Obstet Gynecol 2009;200:357–64.
14. FortyL, SmithD, JonesL, et al. Clinical differences between bipolar and unipolar depression. Br J Psychiatry 2008;192:388–9.
15. NivoliAMA, ColomF, MurruA, et al. New treatment guidelines for acute bipolar depression: a systematic review. J Affect Disord 2011;129:14–26.
16. JiaL, JiangS, ShangY, et al. Investigation of the incidence of pancreatic cancer-related depression and its relationship with the quality of life of patients. Digestion 2010;82:4–9.
17. BreitbartWS, LederbergMS, Rueda-LaraMA, AliciA. Psychosomatic medicine: psycho oncology. In: SadockBJ, SadockVA, RuizP, (Eds.). Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, (9th Edition). Philadelphia: Lippincott Williams and Wilkins; 2009: 2314–53.
18. ShapiroPA, WulsinLR. Psychosomatic medicine: cardiovascular disorders. In: SadockBJ, SadockVA, RuizP, (Eds.). Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, (9th Edition). Philadelphia: Lippincott Williams and Wilkins; 2009: 2250–63.
19. GilbodyS. WhittyP. GrimshawJ. ThomasR. Educational and organizational interventions to improve the management of depression in primary care: a systematic review. JAMA 2003;289:3145–51.
20. SubramaniamH, DennisMS, ByrneEJ. The role of vascular risk factors in late onset bipolar disorder. Int J Geriatr Psychiatry 2007;22:733–7.
21. PanA, SunQ, OkerekeOL, RexrodKM, HuFB. Depression and risk of stroke morbidity and mortalilty. JAMA 2011;306:1241–9.
22. KnolMJ, TwiskJWR, BeekmanATF, et al. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006;49:837–45.
23. CizzaG, PrimmaS, CsakoG. Depression as a risk factor for osteoporosis. Trends Endocrinol Metab 2009;20:367–73.
24. PetriM, NaqibuddinM, CarsonKA, et al. Depression and cognitive impairment in newly diagnosed systemic lupus erythematosis. J Rheumatol 2010;37:2032–8.
25. AgganisBT, WeinerDE, GiangLM, et al. Depression and cognitive function in maintenance hemodialysis patients. Am J Kidney Dis 2010;56:704–12.
26. LesermanJ. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med 2008;70:539–45.
27. ReijndersJ, EhrtU, WeberW, AarslandD, LeentjensA. A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord 2008;23:183–9.
28. PerezDL. CatenaccioE. EpsteinJ. Confusion, hyperactive delirium, and secondary mania in right hemispheric strokes: a focused review of neuroanatomical correlates. J Neurol Neurophysiol 2011;S1:1–5.
29. SpiegelDR, WellerAL, PennellK, TurnerK. The successful treatment of mania due to acquired immunodeficiency syndrome using ziprasidone: a case series. J Neuropsychiatry Clin Neurosci 2010;22:111–14.
30. PopinMK. Consultation-liaison psychiatry. In: JacobsonJL, JacobsonAM, (Eds.). Psychiatric Secrets, (2nd Edition). Philadelphia: Hanley and Belfus; 2004: 381.
31. BoltonJM, RobinsonJ, SareenJ. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions. J Affect Disord 2008;115:367–75.
32. RundDA. EwingJD. MitzelK. VotolatoN. The use of intramuscular benzodiazepines and antipsychotic agents in the treatment of acute agitation or violence in the ED. J Emerg Med 2003;31:317–24.
33. American Psychiatric Association. Practice Guideline for the Assessment and Treatment of Patients with Suicidal Behaviors. 2003. Available at: http://psychiatryonline.org/guidelines.aspex (Accessed February 10, 2012).

References

1. BaraffLJ, JanowiczN, AsarnowJR. Survey of California emergency departments about practices for management of suicidal patients and resources available for their care. Ann Emerg Med 2006;48:452–8.
2. Centers for Disease Control and Prevention, National Hospital Ambulatory Medical Care Survey: 2008 Emergency Department Summary Tables. Available at: http://www.cdc.gov/nchs/fastats/suicide.htm. (Accessed December 30, 2011).
3. XuJ, KochanekKD, MurphySL, et al. Deaths: final data for 2007. National Vital Statistics Reports: 2010;58:19. Available at: http://www.cdc.gov/NCHS/data/nvsr/nvsr58/nvsr58_19.pdf. (Accessed December 30, 2011).
4. National Institute of Mental Health. Available at: http://www.nimh.nih.gov/health/publications/suicide-in-the-us-statistics-and-prevention/index.shtml – CDC-Web-Tool. (Accessed February 8, 2012).
5. Youth Risk Behavior Surveillance (YRBS).2009. http://www.cdc.gov/mmwr/pdf/ss/ss5905.pdf. (Accessed September 15, 2011).
6. MillerM, AzraelD, HemenwayD. The epidemiology of case fatality rates for suicide in the northeast. Ann Emerg Med 2004;43:723–30.
7. MannJJ. A current perspective of suicide and attempted suicide. Ann Intern Med 2002;136:302–11.
8. HirschfeldRM, RussellJM. Assessment and treatment of suicidal patients. N Engl J Med 1997;337:910–15.
9. MoscickiEK. Epidemiology of completed and attempted suicide: toward a framework for prevention. Clin Neurosci Res 2001;1:310–23.
10. Centres for Disease Control and Prevention (CDC). Toxicology testing and results for suicide victims – 113 states, 2004. MMWR Morb Mortal Wkly Rep 2006;55:1245–8.
11. FleischmannA, BertoloteJM, BelferM, et al. Completed suicide and psychiatric diagnoses in young people: a critical examination of the evidence.Am J Orthopsychiatry 2005;75:676–83.
12. BostwickJM, PankratzVS. Affective disorders and suicide risk: a re-examination. Am J Psychiatry 2000;157:1925–32.
13. HorK, TaylorM. Review: suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol 2010;24:81–90.
14. PalmerBA, PankratzVS, BostwickJM. The lifetime risk of suicide in schizophrenia: a re-examination. Arch Gen Psychiatry 2005;62:247–53.
15. InskipHM, HarrisEC, BarracloughB. Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br J Psychiatry 1998;172:35–7.
16. OumayaM, FriedmanS, PhamA, et al. [Article in French] [Borderline personality disorder, self-mutilation and suicide: literature review]. Encephale 2008;34:452–8.
17. American Psychiatric Association Practice guidelines for the assessment and treatment of patients with suicidal behaviors. Am J Psychiatry 2003;160(Suppl):1–60.
18. MittalV, BrownWA, ShorterE. Are patients with depression at heightened risk of suicide as they begin to recover?Psychiatr Serv 2009;60:384–6.
19. BrentDA, PerperJ, MoritzG, et al. Stressful life events, psychopathology, and adolescent suicide: a case control study. Suicide Life Threat Behav 1993;23:179–87.
20. Baca-GarciaE, ParraCP, Perez-RodriguezMM, et al. Psychosocial stressors may be strongly associated with suicide attempts. Stress Health 2007;198:191–8.
21. QinP, NordentoftM. Suicide risk in relation to psychiatric hospitalization: evidence based on longitudinal registers. Arch Gen Psychiatry 2005;62:427–32.
22. BrownGK, BeckAT, SteerRA, et al. Risk factors for suicide in psychiatric outpatients: a 20-year prospective study. J Consult Clin Psychol 2000;68:371–7.
23. CavanaghJ, CarsonA, SharpeM, et al. Psychological autopsy studies of suicide: a systematic review. Psychol Med 2003;33:395–405.
24. OwensD, HorrocksJ, HouseA. Fatal and non-fatal repetition of self-harm: systematic review. Br J Psychiatry 2002;181:193–9.
25. DeMooreGM, RobertsonAR. Suicide in the 18 years after deliberate self-harm a prospective study. Br J Psychiatry 1996;169:489–94.
26. SuominenK, IsometsäE, SuokasJ, et al. Completed suicide after a suicide attempt: a 37-year follow-up study. Am J Psychiatry 2004;161:563–4.
27. StewartSE, ManionIG, DavidsonS, et al. Suicidal children and adolescents with first emergency room presentations: predictors of six month outcome. J Am Acad Child Adolesc Psychiatry 2001;40:580–7.
28. RosewaterKM, BurrBH. Epidemiology, risk factors, intervention, and prevention of adolescent suicide. Curr Opin Pediatr 1998;10:338–43.
29. HawtonK, FaggJ. Suicide, and other causes of death, following attempted suicide. Br J Psychiatry 1988;152:359–66.
30. VyrostekSB, AnnestJL, RyanGW. Surveillance for fatal and nonfatal injuries – United States, 2001. Morb Mortal Wkly Rep 2004;53:1–57.
31. BrentDA, PerperJA, AllmanCJ, et al. The presence and accessibility of firearms in the homes of adolescent suicide: a case-control study. JAMA 1991;266:2989–95.
32. KarchDL, DahlbergLL, PatelN. Surveillance for violent deaths – national violent death reporting system, 16 States, 2007 Surveillance SummariesMMWR Morb Mortal Wkly Rep 2010;59:1–50.
33. SadockBJ, KaplanHI, SadockVA. Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry (10th Edition). Philadelphia: Lippincott Williams & Wilkins; 2007.
34. SmithJC, MercyJA, ConnJM. Marital status and the risk of suicide. Am J Public Health 1988;78:78–80.
35. KposowaAJ.Marital status and suicide in the national longitudinal mortality study. J Epidemiol Community Health 2000;54:254–61.
36. LuomaJB, PearsonJL. Suicide and marital status in the United States, 1991–1996: is widowhood a risk factor?Am J Public Health 2002;92:1518–22.
37. KaplanMS, McFarlandBH, HuguetN, et al. Physical illness, functional limitations, and suicide risk: a population-based study. Am J Orthopsychiatry 2007;77:56–60.
38. GoodwinRD, MarusicA, HovenCW. Suicide attempts in the United States: the role of physical illness. Soc Sci Med 2003;56:1783–8.
39. DrussB, PincusH. Suicidal ideation and suicide attempts in general medical illnesses. Arch Intern Med 2000;160:1522–6.
40. JurrlinkDN, HerrmannN, SzalaiJP, et al. Medical illness and the risk of suicide in the elderly. Arch Intern Med 2004;164:1179–84.
41. KurellaM, KimmelPL, YoungBS, et al. Suicide in the United States end-stage renal disease program. J Am Soc Nephrol 2005;16:774–81.
42. CarricoA, JohnsonM, MorinSF, et al. Correlates of suicidal ideation among HIV-positive persons. AIDS 2007;21:1199–203.
43. BahmanyarS, SparenP, Mittendorfer RutzE, et al. Risk of suicide among operated and non-operated patients hospitalized for peptic ulcers. J Epidemiol Community Health 2009;63:1016–21.
44. HartkoppA, Bronnum-HansenH, SeidenschnurAM, et al. Suicide in a spinal cord injured population: its relation to functional status. Arch Phys Med Rehabil 1998;79:1356–61.
45. BergerD. Suicide risk in the general hospital. Psychiatr Clin Neurosci 1995;49:S85–9.
46. SilenzioVM, PenaJB, DubersteinPR, et al. Sexual orientation and risk factors for suicidal ideation and suicide attempts among adolescents and young adults. Am J Public Health 2007;97:2017–19.
47. HerrellR, GoldbergJ, TrueWR, et al. Sexual orientation and suicidality: a co-twin control study in adult men. Arch Gen Psychiatry 1999;56:867–74.
48. Santa MinaEE, GallopRM. Childhood sexual and physical abuse and adult self-harm and suicidal behaviour: a literature review. Can J Psychiatry 1998;43:793–800.
49. BrodskyBS, OquendoM, EllisSP, et al. The relationship of childhood abuse to impulsivity and suicidal behavior in adults with major depression. Am J Psychiatry 2001;158:1871–7.
50. BrownJ, CohenP, JohnsonJG, et al. Childhood abuse and neglect: specificity of effects on adolescent and young adult depression and suicidality. J Am Acad Child Adolesc Psychiatry 1999;38:1490–6.
51. HoreshN, RolnickT, IancuI, et al. Anger, impulsivity and suicide risk. Psychother Psychosom 1997;66:92–6.
52. ZoukH, TousignantM, SeguinM, et al. Characterization of impulsivity in suicide completers: clinical, behavioral and psychosocial dimensions. J Affect Disord 2006;92:195–204.
53. NockMK, BorgesG, BrometEJ, et al. Suicide and suicidal behavior. Epidemiol Rev 2008;30:133–54.
54. StackS, LesterD. The effect of religion on suicide ideation. Soc Psychiatry Psychiatr Epidemiol 1991;26:168–70.
55. DervicK, OquendoMA, GrunebaumMF, et al. Religious affiliation and suicide attempt. Am J Psychiatry 2004;161:2303–8.
56. PattersonWM, DohnHH, et al. Evaluation of suicidal patients, THE SAD PERSONS Scale. Psychosomatics 1983;24:343–9.
57. SheaSC. The Practical Art of Suicide Assessment: A Guide for Mental Health Professionals and Substance Abuse Counsellors. New York: John Wiley & Sons, Inc; 1999.
58. McDowellAK, LineberryTW, BostwickJM. Practical suicide-risk management for the busy primary care physician. Mayo Clin Proc 2011;86:792–800.
59. BrittonPC, DubersteinPR, ConnerKR, et al. Reasons for living, hopelessness, and suicide ideation among depressed adults 50 years or older. Am J Geriatr Psychiatry 2008;16:736–41.
60. HirschJK, DubersteinPR, ConnerKR. Future orientation and suicide ideation and attempts in depressed adults ages 50 and over. Am J Geriatr Psychiatry 2006;14:752–7.
61. MaloneKM, OquendoMA, GretchenL, et al. Protective factors against suicidal acts in major depression: reasons for living. Am J Psychiatry 2000;157:1084–8.
62. MontrossLP, ZisookS, KasckowJ. Suicide among patients with schizophrenia: a consideration of risk and protective factors. Ann Clin Psychiatry 2005;17:173–82.
63. EdwardsSJ, SachmannMD. No-suicide contracts, no-suicide agreements, and no-suicide assurances: a study of their nature, utilization, perceived effectiveness, and potential to cause harm. Crisis 2010;31:290–302.
64. KellyKT, KnudsonMP. Are no-suicide contracts effective in preventing suicide in suicidal patients seen by primary care physicians?Arch Fam Med 2000;9:1119–21.

References

1. American Psychiatric Association. Somatoform Disorders. Diagnostic and Statistical Manual of Mental Disorders (4th Edition). Text Revision. Washington, DC: American Psychiatric Association; 2000.
2. World Health Organization. International Statistical Classification of Diseases and Related Health Problems: Tenth Revision. Neurotic, Stress-Related and Somatoform Disorders (F40-F48). [http://www.who.int/classifications/icd/en/]. c2007 [Updated November 12, 2006] Available at: http://apps.who.int/classifications/apps/icd/icd10online/ (Accessed August 25, 2011).
3. FinkP, SorensenL, EngbergM, et al. Somatization in primary care: prevalence, health care utilization and general practitioner recognition. Psychosomatics 1999;40:330–8.
4. KroenkeK. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med 2007;69:889–900.
5. SpritzerRL, WilliamsJB, KroenkeK, et al. Utility of a new procedure for diagnosing mental disorders in primary care. JAMA 1994;272:1749–56.
6. OrmelJ, VonkorffM, UstunTB, et al. Common mental disorders and disability across cultures. JAMA 1994;272:1741–8.
7. KroenkeK, SpitzerRL, WilliamsJBW. The phq-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002;64:258–66.
8. KroenkeK, RosmalenJG. Symptoms, syndromes, and the value of psychiatric diagnostics in patients who have functional somatic disorders. Med Clin North Am 2006;90:603–26.
9. LooperKJ, LaurenceJ. Behavioral medicine approaches to somatoform disorders. J Consult Clin Psychol 2002;70:810–27.
10. BarskyAJ, OravEJ, BatesDW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 2005;62:903–10.
11. KrahnLE, BostwickJM, StonningtonCM. Looking toward DSM-V: should factitious disorder become a subtype of somatoform disorder?Psychosomatics 2008;49:277–82.
12. LiebR, MeinlschmidtG, ArayaR. Epidemiology of the association between somatoform disorders and anxiety and depressive disorders: an update. Psychosom Med 2007;69:860–3.
13. LoweB, SpitzerRL, WilliamsJB, et al. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiatry 2008;30:191–9.
14. VoightK, NagelA, MeyerB, et al. Towards positive diagnostic criteria: a systematic review of somatoform disorder diagnoses and suggestions for future classification. J Psychosom Res 2010;68:403–14.
15. ReifW, IsaacM. Are somatoform disorders ‘mental disorders’? A contribution to the current debate. Curr Opin Psychiatry 2007;20:143–6.
16. RiefW, RojasG. Stability of somatoform symptoms – implications for classification. Psychosomatics 2007;48:277–85.
17. KroenkeK, SharpeM, SykesR. Revising the classification of somatoform disorders: key questions and preliminary recommendations. Psychosomatics 2008;49:362.
18. MayouR, KirymayerLJ, SimonG, et al. Somatoform disorders: time for a new approach in DSM-V. Am J Psychiatry 2005;162:847–55.
19. FavaGA, FabbriS, SirriL, et al. Psychological factors affecting medical condition: a new proposal for DSM-V. Psychosomatics 2007;48:103–11.
20. StephensonDT, PriceJR. Medically unexplained physical symptoms in emergency medicine. Emerg Med J 2006;23:595–600.
21. FeinsteinA. Conversion disorder: advances in our understanding. CMAJ 2011;183:915–20.
22. StoneJ, SmythR, CarsonA, et al. La belle indifférence in conversion symptoms and hysteria: systematic review. Br J Psychiatry 2006;188:204–9.
23. Eberhard-GranM, ScheiB, EskildA. Somatic symptoms and diseases are more common in women exposed to violence. J Gen Intern Med 2007;22:1668–73.
24. TomassonK, KentD, CoryellW. Somatization and conversion disorders: co-morbidity and demographics at presentation. Acta Psychiatr Scand 1991;84:288–93.
25. BrowningM, FletcherP, SharpM. Can neuroimaging help us to understand and classify somatoform disorders? A systematic and critical review. Psychosom Med 2011;73:173–84.
26. Van BeilenM, VogtB, LeendersK. Increased activation in cingulate cortex in conversion disorder: what does it mean?J Neurol Sci 2010;289:155–8.
27. GhaffarO, StainesR, FeinsteinA. Unexplained neurologic symptoms: an fMRI study of sensory conversion disorder. Neurology 2006;7:2036–8.
28. VoonV, BrezingC, GalleaC, et al. Emotional stimuli and motor conversion disorder. Brain 2010;133:1526–36.
29. VoonV, GalleaC, HattoriN, et al. The involuntary nature of conversion disorder. Neurology 2010;74:223–8.
30. TunkaZ, ErgeneU, FidanerH, et al. Reevaluation of serum cortisol in conversion disorder with seizure (pseudoseizure). Psychosomatics 2000;41:152–3.
31. SharpeM, CarsonA. “Unexplained” somatic symptoms, functional syndromes, and somatization: do we need a paradigm shift?Ann Intern Med 2001;134:926–30.
32. KeefeFJ, LumleyMA, BuffingtonAL, et al. Changing face of pain: evolution of pain research in psychosomatic medicine. Psychosom Med 2002;64:921–38.
33. MarazzitiD, MungaiF, VivarelliL, PrestaS, Dell’OssoB.Pain and psychiatry: a critical analysis and pharmacological review. Clin Pract Epidemiol Ment Health 2006;2:31.
34. ChouR, FanciulloGJ, FinePG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009;22:113–30.
35. AbramowitzJS, BraddockAE. Hypochondriasis: conceptualization, treatment, and relationship to obsessive-compulsive disorder. Psychiatr Clin North Am 2006;29:503–19.
36. BarskyAJ, AhernDK, BaileyD, et al. Hypochondriacal patients’ appraisal of health and physical risks. Am J Psychiatry 2001;158:783–7.
37. PavanC, SimonatoP, MariniM, et al. Psychopathologic aspects of body dysmorphic disorder: a literature review. Aesthetic Plast Surg 2008;32:473–84.
38. MayouR, KrmayerLJ, SimonG, et al. Somatoform disorders: time for a new approach in DSM-V. Am J Psychiatry 2005;162:847–55.
39. SarwerDB, CrerandCE, DidieER. Body dysmorphic disorder in cosmetic surgery patients. Facial Plast Surg 2003;19:7–18.
40. MackleyCL. Body dysmorphic disorder. Dermatol Surg 2005;31:553–8.
41. SmallGW. Pseudocyesis: an overview. Can J Psychiatry 1986;31:452–7.
42. TrivediAN, SinghS. Pseudocyesis and its modern perspective. Aust N Z J Obstet Gynaecol 1998;38:466–8.
43. SamaA, ChaneyC, JonesCA. ACEP Policy Compendium. American College of Emergency Physicians [internet compendium]. 2011. Available at: www.acep.org/workarea/downloadasset.aspx?id=76542 (Accessed August 28, 2011).
44. NawarEW, NiskaRW, XuJ. National Hospital Ambulatory Medical Care Survey: 2005 Emergency Department Summary. Advance data from vital health statistics; no. 386. Hyattsville, MD: National Center for Health Statistics; 2007.
45. EpsteinRM, ShieldsCG, MeldrumSC, et al. Physician’s responses to patients’ medically unexplained symptoms. Psychosom Med 2006;68:269–76.
46. ThompsonAW, HantkeBA, PhatakV, et al. The personality assessment inventory as a tool for diagnosing psychiatric non-epileptic seizures. Epilepsia 2010;51:161–4.
47. KroenkeK, SpitzerRL, WilliamsJB, et al. The patient health questionnaire somatic, anxiety, and depressive symptoms scales: a systematic review. Gen Hosp Psychiatry 2010;32:345–59.
48. SalmonP, PetersS, StanleyI. Patients’ perceptions of medical explanations for somatization disorders: qualitative analysis. BMJ 1999;318:372–6.
49. MayouR.Medically unexplained physical symptoms. BMJ 1991;303:534–5.
50. McCahillME.Somatoform and related disorders: delivery of diagnosis as first step. Am Fam Physician 1995;52:193–204.
51. SumathipalaA.What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med 2007;69:889–900.
52. SireyJA, BruceML, AlexopoulosGS, et al. Stigma as a barrier to recovery: perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv 2001;52:1615–20.
53. HurwitzTA, PrichardJW. Conversion disorder and fMRI. Neurology 2006;67:1914–15.
54. BleichhardtG, TimmerB, ReifW. Cognitive behavioral therapy for patients with multiple somatoform symptoms-a randomized controlled trial in tertiary care. J Psychosom Res 2004;56:449–54.
55. ManchikantiL, GiordanoJ, BoswellMV, et al. Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. J Opioid Manag 2007;3:89–100.
56. O’MalleyPG, JacksonJL, SantoroJ, et al. Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract 1999;48:980–90.
57. FallonBA. Pharmacotherapy of somatoform disorders. J Psychosom Res 2004;56:455–60.
58. IpserJC, SanderC, SteinDJ. Pharmacotherapy and psychotherapy for body dysmorphic disorder. Cochrane Database Syst Rev 2009;1:CD005332.
59. RosenblumA, MarschLA, JosephH, et al. Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol 2008;16:405–16.

References

1. Brawman-MitnzerO.Generalized Anxiety Disorder. The Psychiatric Clinics of North America. Philadelphia: W.B. Saunders Company 2001;24:xi–xii.
2. OyewumiLK, OdejideO, KazariannSS.Psychiatric emergency services in a Canadian city: II. Clinical characteristics and patients’ disposition. Can J Psychiatry 1992;37:96–9.
3. MarxJ, HockbergerR, WallsR, (Eds.). Rosen’s Emergency Medicine Concepts and Clinical Practice (7th Edition, Chapter 110). Philadelphia: Mosby/Elsevier; 2010: 1445–51.
4. BallengerJC, DavidsonJR, LecrubierY, et al. Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry 2001;62:53–8.
5. DemiryoguranNS, KarciogluO, TopacogluH.Anxiety disorder in patients with non-specific chest pain in the emergency setting. Emerg Med J 2006;23:99–102.
6. IsbergRS.Emergency care of anxious patients. In: BassukEL, (Ed.). Emergency Psychiatry: Concepts, Methods, and Practices. New York: Plenum Press; 1984: 233–60.
7. MilnerKK, FlorenceT, GlickRL.Mood and anxiety syndromes in emergency psychiatry. Psychiatr Clin North Am 1999;22:766–77.
8. SheltonR.Current diagnosis and treatment: psychiatry. In: EbertM, LosenP, (Eds.). Anxiety Disorders, (2nd Edition, Chapt. 22). Columbus, OH: McGraw-Hill Companies; 2008: 328–41.
9. WHO. ICD-10 Classification of Mental and Behavioral Disorders, Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO; 1992.
10. WittchenHU, GlosterAT.Developments in the treatment and diagnosis of anxiety disorders. Psychiatr Clin North Am 2009;32:XIII–XX.
11. Inter-University Consortium for Social and Political Research. Epidemiologic Catchment Area Study, 1980–1985 [United States]. Available at: http://www.icpsr.umich.edu/icpsrweb/ICPSR/studies/06153.
12. KurlanR, ComoPG, MillerB, et al. The behavioral spectrum of tic disorders: a community-based study. Neurology 2002;59:414–20.
13. MaierW, FalkaiP.The epidemiology of comorbidity between depression, anxiety disorders and somatic diseases. Int Clin Psychopharmacol 1999;14(Suppl 2):S1–6.
14. SadockBJ, SadockVA.Panic disorder and agoraphobia. In: Kaplan and Sadock’s Synopsis of Psychiatry Behavioral Sciences/ Clinical Psychiatry, (10th Edition). Philadelphia: Lippincott Williams & Wilkins; 2007.
15. PollardCA, LewisLM.Managing panic attacks in emergency patients. J Emerg Med 1989;7:547–52.
16. LaderMH, UhdeTW.Fast Facts: Anxiety, Panic, and Phobias, (2nd Edition). Oxford, UK: Health Press Limited; May 2006.
17. OtteC.Cognitive behavioral therapy in anxiety disorders: current state of the evidence. Dialogues Clin Neurosci 2011;13:413–21.
18. HuhJ, GoebertD, TakeshitaJ, LuBY, KangM.Treatment of generalized anxiety disorder: a comprehensive review of the literature for psychopharmacologic alternatives to newer antidepressants and benzodiazepines. Prim Care Companion CNS Disord 2011;13:pii.
19. Foldes-BusqueG, FleetR, PoitrasJ, et al. Preliminary investigation of the Panic Screening Score for emergency department patients with unexplained chest pain. Acad Emerg Med 2011;18:322–5.

References

1. LondonRT.PTSD: another great masquerader [“The Psychiatrist’s Toolbox”]. Clinical Psychiatry News 2009;37:23.
2. YehudaR.Post-traumatic stress disorder. N Engl J Med 2002;346:108–14.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR, (4th Edition). Washington, DC: American Psychiatric Publishing, Inc; 2000.
4. MarshallRD, OlfsonM, HellmanF, et al. Comorbidity, impairment, and suicidality in subthreshold PTSD. Am J Psychiatry 2001;158:1467–73.
5. ShayJ.Learning about combat stress from Homer’s Iliad. J Trauma Stress 1991;4:561–79.
6. JonesFD, SparacinoLR, WilcoxVL, RothbergJM, StokesJW.War psychiatry. In: ZajtchukR, BellamyRF, (Eds.). Textbook of Military Medicine. Washington, DC: Department of the Army, Office of The Surgeon General, Borden Institute; 1995.
7. GrinkerRR, SpiegelJ.Men Under Stress. Philadelphia: Blakiston; 1945.
8. OttoMW, HeninA, Hirshfeld-BeckerDR, et al. Posttraumatic stress disorder symptoms following media exposure to tragic events: impact of 9/11 on children at risk for anxiety disorders. Anxiety Disord 2007;21:888–902.
9. FigleyCR.Compassion fatigue: psychotherapists chronic lack of self care. J Clin Psychol 2002; 58:1433–41.
10. SadockBJ, SadockVA.Anxiety disorders: clinical features. In Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, (8th Edition. Chapt. 14.8). Philadelphia: Lippincott Williams and Wilkins; 2005.
11. ButlerDJ, MofficHS, TurkalNW.Post-traumatic stress reactions following motor vehicle accidents. Am Fam Physician 1999;60:524–31.
12. KhallafiH, ChackoV, VarveralisN, ElmiF.“Broken heart syndrome”: catecholamine surge or aborted myocardial infarction?. J Invasive Cardiol 2008;20:9–13.
13. DorfmanTA, IskandrianAE.Takotsubo cardiomyopathy: state-of-the-art review. J Nucl Cardiol 2009;16:122–34.
14. BoscarinoJA.Posttraumatic stress disorder, exposure to combat, and lower plasma cortisol among Vietnam veterans: findings and clinical implications. J Consul Clin Psychol 1996;64:191–201.
15. KatsouyanniK, KogevinasM, TrichopoulusM.Earthquake-related stress and cardiac mortality. Int J Epidemiol 1986;15:326.
16. SegalJ, HunterEJ, SegalZ.Universal consequences of captivity: stress reactions among divergent populations of prisoners of war and their families. Int J Soc Sci 1976;28:593–609.
17. Van der KolkBA, McFarlaneAC, WeisaethL, (Eds.). Traumatic Stress: The Effects of Overwhelming Experience on Mind, Body, and Society. New York: Guilford Press; 1996.
18. ClaytonNM, NashWP.Medication management of combat and operational stress injuries in active duty service members. In: FigleyCR, NashWP, (Eds.). Combat Stress Injury. New York: Routledge; 2007: 219–45.
19. HermanJL.Trauma and Recovery. New York: Basic Books; 1997.
20. RamaswamyS, MadaanV, QadriF, et al. A primary care perspective of posttraumatic stress disorder for the Department of Veterans Affairs. Prim Care Companion J Clin Psychiatry 2005;7:180–7.
21. PrinsA, OuimetteP, KimerlingR, et al. The primary care PTSD screen (PC-PTSD): development and operating characteristics. Prim Care Psychiatry 2003;9:9–14.
22. PrinsA, OuimetteP, KimerlingR, et al. The primary care PTSD screen (PC-PTSD): corrigendum. Prim Care Psychiatry 2004;9:151.
23. LenehanGP.A SANE way to care for rape victims. J Emerg Nurs 1991;17:1–2.
24. LedrayLE.The sexual assault resource service: a new model of care. Minn Med 1996;79:43–5.
25. EhlersA, ClarkDM.A cognitive model of post-traumatic stress disorder. Behav Res Ther 1999;38:319–45.
26. ShemeshE, RudnickA, KaluskiE, et al. A prospective study of posttraumatic stress symptoms and nonadherence in survivors of a myocardial infarction (MI). Gen Hosp Psychiatry 2001;23:215–22.
27. LazareA.Shame and humiliation in the medical encounter. Arch Intern Med 1987;147:1653–8.
28. RichmondJS, BeckJC.Post traumatic stress disorder in a World War II veteran. (letter). Am J Psychiatry 1986;143:1458–86.
29. U.S. Department of Veterans Affairs. VA/DoD Clinical Practice Guidelines-Management of Traumatic Stress Disorder and Acute Stress Reaction [Internet]. 2010. Available at: http://www.healthquality.va.gov/PTSD-FULL-2010c.pdf (Accessed September 26, 2011).
30. DavidsonJR, RothbaumBO, van der KolkBA, SikesCR, FarfelGM.Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry 2001;58:485–92.
31. ConnorKM, SutherlandSM, TuplerLA, MalikML, DavidsonJR.Fluoxetine in post-traumatic stress disorder: randomised, double-blind study. Br J Psychiatry 1999;175:17–22.
32. BraunP, GreenbergD, DasbergH, LererB.Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J Clin Psychiatry 1990;51:236–8.
33. GelpinE, BonneO, PeriT, BrandesD, ShalevAY.Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry 1996;57:390–4.
34. U.S. Department of Veterans Affairs. National Center for PTSD. Mobile App: PTSD Coach [Internet]. 2011 [updated July 7, 2011]. Available at: http://www.ptsd.va.gov/public/pages/ptsdcoach.asp (Accessed September 25, 2011).
35. RothbaumBO, HodgesLF, ReadyD, GraapK, AlarconRD.Virtual reality exposure therapy for Vietnam veterans with posttraumatic stress disorder. J Clin Psychiatry 2001;62:617–22.
36. DifedeJ, HoffmanHG.Virtual reality exposure therapy for World Trade Center post-traumatic stress disorder: a case report. Cyberpsychol Behav 2002;5:529–35.
37. KesslerRC, SonnegaA, BrometE, HughesM, NelsonCB.Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995;52:1048–60.

References

1. JibsonMD.Overview of Psychosis. Waltham, MA: UpToDate; (2010). Available at: http://www.uptodateonline.com (Accessed August 10, 2012).
2. PeralaJ, SuvisaariJ, SaarniS, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007;64:19–28.
3. NurcombeB, EbertMH.The psychiatric interview. In: EbertMH, LoosenPT, NurcombeB, LeckmanJF, (Eds.). Current Diagnosis & Treatment in Psychiatry, (2nd Edition, Chapt. 4). New York: McGraw-Hill; 2008.
4. RopperAH, SamuelsMA.Coma and related disorders of consciousness. In: RopperAH, SamuelsMA, (Eds.). Adams and Victor’s Principles of Neurology, (9th Edition, Chapt. 17). New York: McGraw-Hill; 2009.
5. PatkarA, MagoR, MasandP.Psychotic symptoms in patients with medical disorders. Curr Psychiatry Rep 2004;6:216–24.
6. KhuranaV, GambhirIS, KishoreD.Evaluation of delirium in the elderly: a hospital-based study. Geriatr Gerontol Int 2011;11:467–73.
7. BabuK, BoyerE.Emergency Department Evaluation of Acute Onset Psychosis in Children. Waltham, MA: UpToDate. Available at: http://www.uptodateonline.com.
8. RopperAH, SamuelsMA.Delirium and other acute confusional states. In: RopperAH, SamuelsMA, (Eds.). Adams and Victor’s Principles of Neurology, (9th Edition, Chapt. 20). New York: McGraw-Hill; 2009.
9. HanJ, WilsonA,ElyE.Delirium in the older emergency department patient: a quiet epidemic. Emerg Med Clin North Am 2010;28:611–31.
10. TakeuchiA, AhernTL,HendersonSO.Excited delirium. West J Emerg Med 2011;12:77–83.
11. VilkeGM, SloaneC, LevineS, et al. Twelve-lead electrocardiogram monitoring of subjects before and after voluntary exposure to the Taser X26. Am J Emerg Med 2008;26:1–4.
12. SloaneCM, ChanTC, LevineSD, et al. Serum troponin I measurement of subjects exposed to the Taser X-26. J Emerg Med 2008:35:29–32.
13. ChanTC, VilkeGM, NeumanT.Restraint position and positional asphyxia. Am J Forensic Med Pathol 2000;21:93.
14. AciolyMA, CarvalhoCH, TatagibaM, et al. The parahippocampal gyrus as a multimodal association area in psychosis. J Clin Neurosci 2010;17:1603–5.
15. de Araújo FilhoGM, da SilvaJM, MazettoL, et al. Psychoses of epilepsy: a study comparing the clinical features of patients with focal versus generalized epilepsies. Epilepsy Behav 2011;20:655–8.
16. SchlittM, LakemanFD, WhitleyRJ.Psychosis and herpes simplex encephalitis. South Med J 1985;78:1347–50.
17. RopperAH, SamuelsMA.Neurologic disorders caused by lesions in specific parts of the cerebrum. In: RopperAH, SamuelsMA, (Eds.). Adams and Victor’s Principles of Neurology, (9th Edition, Chapt. 22). Waltham, MA: McGraw-Hill; 2009.
18. LoringKE, TintinalliJE.Central nervous system and spinal infections. In: TintinalliJE, StapczynskiJS, ClineDM, et al., (Eds.). Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, (7th Edition, Chapt. 168). New York: McGraw-Hill; 2011.
19. IglewiczA, MeeksTW, JesteDV.New wine in old bottle: late-life psychosis. Psychiatr Clin North Am 2011;34:295–318.
20. DevlinRJ, HenryJA.Major consequences of illicit drug consumption. Crit Care 2008;12:202.
21. BishopAG, TallonJM.Anticholinergic visual hallucinosis from atropine eye drops. CJEM 1999;1:115–16.
22. RopperAH, SamuelsMA.Disorders of the nervous system caused by drugs, toxins, and other chemical agents. In: RopperAH, SamuelsMA, (Eds.). Adams and Victor’s Principles of Neurology, (9th Edition, Chapt. 43). New York: McGraw-Hill; 2009.
23. MooreJW, TurnerDC, CorlettPR, et al. Ketamine administration in healthy volunteers reproduces aberrant agency experiences associated with schizophrenia. Cogn Neuropsychiatry 2011;6:1–18.
24. PrybysKM, HansenKN.Hallucinogens. In: TintinalliJE, StapczynskiJS, ClineDM, et al., (Eds.). Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, (7th Edition, Chapt. 182). New York: McGraw-Hill; 2011.
25. Wax PaulM, Young AmyC.Anticholinergics. In: TintinalliJE, StapczynskiJS, ClineDM, et al., (Eds.). Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, (7th Edition, Chapt. 196). New York: McGraw-Hill; 2011.
26. DeBellisR, SmithB, ChoiS, et al. Management of delirium tremens. J Intensive Care Med 2005;20:164.
27. ShirleyKW, KothareS, PiattJ, et al. Intrathecal baclofen overdose and withdrawal. Pediatr Emerg Care 2006;22:258–61.
28. MalhortaT,RosenzweigI.Baclofen withdrawal causes psychosis in otherwise unclouded consciousness. J Neuropsychiatry Clin Neurosci 2009;21:476.
29. DawsonKL,CarterER.A steroid-induced acute psychosis in a child with asthma. Pediatr Pulmonol 1998;26:362–4.
30. PrzekoP, LeeT.Persistent psychosis associated with salvia divinorum use. Am J Psychiatry 2009;166:832.
31. Centers for Disease Control and Prevention (CDC). Emergency department visits after use of a drug sold as “bath salts” – Michigan, November 13, 2010-March 31, 2011. MMWR Morb Mortal Wkly Rep 2011 May 20;60:624–7.
32. HuX, PrimackBA, BarnettTE, et al. College students and use of K2: an emerging drug of abuse in young persons. Subst Abuse Treat Prev Policy 2011;6:16.
33. ZimmermannUS, WinkelmannPR, PilhatschM, et al. Withdrawal phenomena and dependence syndrome after the consumption of “spice gold”. Dtsch Arztebl Int 2009;106:564–7.
34. NeuroSoup. List of Synthetic Cannabinoids. Available at: http://www.neurosoup.com (Accessed September 30, 2011).
35. RodgmanC, KinzieE, LeimbachE.Bad Mojo: use of the new marijuana substitute leads to more and more ED visits for acute psychosis. Am J Emerg Med 2011;29:232.
36. PendersTM, GestringR.Hallucinatory delirium following use of MDPV: “Bath Salts”. Gen Hosp Psychiatry 2011;33:525–6.
37. SahaS, ChantD, WelhamJ, et al. A systematic review of the prevalence of schizophrenia. PLoS Med 2005;2:e141.
38. RopperAH, SamuelsMA.The schizophrenias and paranoid states. In: RopperAH, SamuelsMA, (Eds.). Adams and Victor’s Principles of Neurology, (9th Edition, Chapt. 58). New York: McGraw-Hill; 2009.
39. MerikangasKR, AkiskalHS, AngstJ, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007;64:543–52. Erratum in: Arch Gen Psychiatry 2007;64:1039.
40. BellivierF, YonL, LuquiensA, et al. Suicidal attempts in bipolar disorder: results from an observational study (EMBLEM). Bipolar Disord 2011:13:377–86.
41. LoosenPT, SheltonRC.Mood disorders. In: EbertMH, LoosenPT, NurcombeB, LeckmanJF, (Eds.). Current Diagnosis & Treatment: Psychiatry, (2nd Edition, Chapt. 18). New York: McGraw Hill; 2008.
42. SheltonRC.Other psychotic disorders. In: EbertMH, LoosenPT, NurcombeB, LeckmanJF, (Eds.). Current Diagnosis & Treatment: Psychiatry, (2nd Edition, Chapt. 17). New York: McGraw-Hill; 2008.
43. MosholderAD, GelperinK, HammadT, et al. Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children. Pediatrics 2009;123:611.
44. MuscalE, NadeemT, LiX, et al. Evaluation and treatment of acute psychosis in children with Systemic Lupus Erythematosus (SLE): consultation-liaison service experiences at a tertiary-care pediatric institution. Psychosomatics 2010;51:508–14.
45. SibbittWL Jr, BrandtJR, JohnsonCR, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 2002;29:1536–42.
46. McDonaldLV, LakeCR.Psychosis in an adolescent patient with Wilson’s disease: effects of chelation therapy. Psychosom Med 1995;57:202–4.
47. RopperAH, SamuelsMA.Inherited metabolic diseases of the nervous system. In: RopperAH, SamuelsMA, (Eds.). Adams and Victor’s Principles of Neurology, (9th Edition, Chapt. 37). New York: McGraw-Hill; 2011.
48. BhangooRK, CarterCS.Very early interventions in psychotic disorders. Psychiatr Clin North Am 2009:32:81–94.
49. GochmanP, MillerR,RapoportJL.Childhood-onset schizophrenia: the challenge of diagnosis. Curr Psychiatry Rep 2011;13:321–2.
50. DavidCN, GreensteinD, ClasenL, et al. Childhood onset schizophrenia: high rate of visual hallucinations. J Am Acad Child Adolesc Psychiatry 2011;50:681–686.e3.
51. WashburnJJ, WestAE, HeilJA.Treatment of pediatric bipolar disorder: a review. Minerva Psichiatr 2011;52:21–35.
52. AminoffMJ, KerchnerGA.Nervous system disorders. In: McPheeSJ, PapadakisMA, RabowMW, (Eds.). Current Medical Diagnosis & Treatment 2012, (Chapt. 24). New York: McGraw-Hill; 2011.
53. LusskinS,MisriS.Psychosis and Pregnancy. Waltham, MA: UpToDate. Available at: http://www.uptodateonline.com.
54. MeyerJM.Pharmacotherapy of psychosis and mania. In: BruntonLL, ChabnerBA, KnollmannBC, (Eds.). Goodman & Gilman’s The Pharmacological Basis of Therapeutics, (12th Edition, Chapt. 16). New York: McGraw-Hill; 2011.
55. LadavacAS, DubinWR, NingA, et al. Emergency management of agitation in pregnancy. Gen Hosp Psychiatry 2007;29:39–41.
56. SpinelliMG.Postpartum psychosis: detection of risk and management. Am J Psychiatry 2009;166:405–8.
57. LusskinSI, MisriS.Postpartum Psychosis: Treatment. Waltham, MA: UpToDate. Available at: http://www.uptodateonline.com.
58. ChandraPS, BhargavaramanRP, RaghunandanVN, et al. Delusions related to infant and their association with mother-infant interactions in postpartum psychotic disorders. Arch Womens Ment Health 2006;9:285–8.
59. SpinelliMG.A systematic investigation of 16 cases of neonaticide. Am J Psychiatry 2001;158:811–13.
60. MarcoCA, VaughanJ.Emergency management of agitation in schizophrenia. Am J Emerg Med 2005;23:767–76.
61. LukensTW, WolfSJ, EdlowJA, et al. American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Critical Issues in the Diagnosis and Management of the Adult Psychiatric Patient in the Emergency Department. Clinical policy: critical issues in the diagnosis and management of the adult psychiatric patient in the emergency department. Ann Emerg Med 2006;47:79–99.
62. KapurR, FinkES.The violent patient. In: TintinalliJE, StapczynskiJS, ClineDM, et al., (Eds.). Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, (7th Edition, Chapt. e293.1). New York: McGraw-Hill; 2011.
63. AccessMedicine. Drug Monographs. The McGraw-Hill Companies. Available at: http://www.accessmedicine.com.
64. KaoLW, KirkMA, EversSJ, et al. Droperidol, QT prolongation, and sudden death: what is the evidence?Ann Emerg Med 2003;41:546–58.
65. ShaleJH, ShaleCM, MastinWD.A review of the safety and efficacy of droperidol for the rapid sedation of severely agitated and violent patients. J Clin Psychiatry 2003;64:500–5.

References

1. AdamsJ, MurrayR, III. The general approach to the difficult patient. Emerg Med Clin North Am 1998;16:689–700.
2. SpenceJM, BergmansY, StrikeC, et al. Experiences of substance-using suicidal males who present frequently to the emergency department. CJEM 2008;10:339–46.
3. SamuelsJ.Personality disorders: epidemiology and public health issues. Int Rev Psychiatry 2011;23:223–33.
4. BruffaertsR, SabbeM, DemyttenaereK.Who visits the psychiatric emergency room for the first time?Soc Psychiatry Psychiatr Epidemiol 2006;41:580–6.
5. LeeHB, BienvenuOJ, ChoSJ, et al. Personality disorders and traits as predictors of incident cardiovascular disease: findings from the 23-year follow-up of the Baltimore ECA study. Psychosomatics 2010;51:289–96.
6. KendlerKS, AggenSH, CzajkowskiN, et al. The structure of genetic and environmental risk factors for DSM-IV personality disorders: a multivariate twin study. Arch Gen Psychiatry 2008;65:1438–46.
7. Jonson-ReidM,PresnallN, DrakeB, et al. Effects of child maltreatment and inherited liability on antisocial development: an official records study. J Am Acad Child Adolesc Psychiatry 2010;49:321–32.
8. CaspiA, McClayJ, MoffittTE, et al. Role of genotype in the cycle of violence in maltreated children. Science 2002;297:851–4.
9. FinebergNA, SharmaP, SivakumaranT, SahakianB, ChamberlainSR.Does obsessive-compulsive personality disorder belong within the obsessive-compulsive spectrum?CNS Spectr 2007;12:467–82.
10. TarboxSI, Pogue-GeileMF.A multivariate perspective on schizotypy and familial association with schizophrenia: a review. Clin Psychol Rev 2011;31:1169–82.
11. FogelsonDL, AsarnowRA, SugarCA, et al. Avoidant personality disorder symptoms in first-degree relatives of schizophrenia patients predict performance on neurocognitive measures: the UCLA family study. Schizophr Res 2010;120:113–20.
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Text Revision (Fourth Edition). Washington, DC: American Psychiatric Association; 2000.
13. HopwoodCJ, MaloneJC, AnsellEB, et al. Personality assessment in DSM-5: empirical support for rating severity, style, and traits. J Pers Disord 2011;25:305–20.
14. TyrerP, CrawfordM, MulderR, ICD-11 Working Group for the Revision of Classification of Personality Disorders. Reclassifying personality disorders. Lancet 2011;377:1814–15.
15. TragesserSL, TrullTJ, SherKJ, ParkA.Drinking motives as mediators in the relation between personality disorder symptoms and alcohol use disorder. J Pers Disord 2008;22:525–37.
16. Di SclafaniV, FinnP, FeinG.Psychiatric comorbidity in long-term abstinent alcoholic individuals. Alcohol Clin Exp Res 2007;31:795–3.
17. FentonMC, KeyesK, GeierT, et al. Psychiatric comorbidity and the persistence of drug use disorders in the United States. Addiction 2012;107:599–609.
18. FlanneryRB Jr, WalkerAP.Repetitively assaultive psychiatric patients: fifteen-year analysis of the Assaulted Staff Action Program (ASAP) with implications for emergency services. Int J Emerg Ment Health 2008;10:1–8.
19. GrannM, DaneshJ, FazelS.The association between psychiatric diagnosis and violent re-offending in adult offenders in the community. BMC Psychiatry 2008;8:92.
20. OuimettePC, GimaK, MoosRH, FinneyJW.A comparative evaluation of substance abuse treatment IV. The effect of comorbid psychiatric diagnoses on amount of treatment, continuing care, and 1-year outcomes. Alcohol Clin Exp Res 1999;23:552–7.
21. HumphreysK, MoosRH.Encouraging posttreatment self-help group involvement to reduce demand for continuing care services: two-year clinical and utilization outcomes. Alcohol Clin Exp Res 2007;31:64–8.
22. Reichborn-KjennerudT, CzajkowskiN, RoysambE, et al. Major depression and dimensional representations of DSM-IV personality disorders: a population-based twin study. Psychol Med 2010;40:1475–84.
23. BeautraisAL, JoycePR, MulderRT, et al. Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: a case-control study. Am J Psychiatry 1996;153:1009–14.
24. HenrikssonMM, AroHM, MarttunenMJ, et al. Mental disorders and comorbidity in suicide. Am J Psychiatry 1993;150:935–40.
25. PulayAJ, DawsonDA, HasinDS, et al. Violent behavior and DSM-IV psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2008;69:12–22.
26. ShepherdJP, ShepherdI, NewcombeRG, FarringtonD.Impact of antisocial lifestyle on health: chronic disability and death by middle age. J Public Health (Oxf) 2009;31:506–11.
27. WagnerJA, PietrzakRH, PetryNM.Psychiatric disorders are associated with hospital care utilization in persons with hypertension: results from the National Epidemiologic Survey on alcohol and related conditions. Soc Psychiatry Psychiatr Epidemiol 2008;43:878–88.
28. KleinM.Notes on some schizoid mechanisms. Int J Psychoanal 1946;27:99–110.
29. RackerH.The meanings and uses of countertransference. Psychoanal Q 1957;26:303–57.
30. GalleseV, EagleMN, MigoneP.Intentional attunement: mirror neurons and the neural underpinnings of interpersonal relations. J Am Psychoanal Assoc 2007;55:131–76.
31. PompiliM, GirardiP, RubertoA, TatarelliR.Suicide in borderline personality disorder: a meta-analysis. Nord J Psychiatry 2005;59:319–24.
32. YenS, PaganoME, SheaMT, et al. Recent life events preceding suicide attempts in a personality disorder sample: findings from the collaborative longitudinal personality disorders study. J Consult Clin Psychol 2005;73:99–105.
33. HolmesTH, RaheRH.The Social Readjustment Rating Scale. J Psychosom Res 1967;11:213–18.
34. Blasco-FontecillaH, Baca-GarciaE, DubersteinP, et al. An exploratory study of the relationship between diverse life events and specific personality disorders in a sample of suicide attempters. J Pers Disord 2010;24:773–84.
35. RuddMD, BermanAL, JoinerTE Jr, et al. Warning signs for suicide: theory, research, and clinical applications. Suicide Life Threat Behav 2006;36:255–62.
36. AmoreM, MenchettiM, TontiC, et al. Predictors of violent behavior among acute psychiatric patients: clinical study. Psychiatry Clin Neurosci 2008;62:247–55.
37. HerbertPB, YoungKA.Tarasoff at twenty-five. J Am Acad Psychiatry Law 2002;30:275–81.
38. AllenMH, CurrierGW, CarpenterD, et al. The expert consensus guideline series. Treatment of behavioral emergencies 2005. J Psychiatr Pract 2005;11(Suppl 1):5–108.
39. MatusiewiczAK, HopwoodCJ, BanducciAN, LejuezCW.The effectiveness of cognitive behavioral therapy for personality disorders. Psychiatr Clin North Am 2010;33:657–85.

References

1. FolksDG, FordCV, HouckiCA.Somatoform disorders, factitious disorders, and malingering. In: StoudemireA, (Ed.). Clinical Psychiatry for Medical Students, (3rd Edition). Philadelphia: Lippincott-Raven Publishers; 1998.
2. HollifieldMA.Somatization disorder. In: SadockBJ, SadockVA, (Eds.). Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, (8th Edition). Philadelphia: Lippincott Williams & Wilkins; 2005.
3. McDermottBE, FeldmanMD.Malingering in the medical setting. Psychiatr Clin N Am 2007;30:645–62.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Text Revision (4th Edition). Washington, DC: American Psychiatric Association; 2000.
5. DimsdaleJ, CreedF.The proposed diagnosis of somatic symptom disorders in DSM-V to replace somatoform disorders in DSM-IV–a preliminary report. J Psychosomatic Res 2009;66:473–6.
6. EpsteinLA, SternTA.Factitious disorders and malingering. In: GlickRL, BerlinJS, FishkindAB, ZellerSL, (Eds.). Emergency Psychiatry, Principles and Practice. Philadelphia: Lippincott Williams & Wilkins; 2008.
7. KrahnLE, LiH, O’ConnorMK.Patients who strive to be ill: factitious disorder with physical symptoms. Am J Psychiatry 2003;160:1163–8.
8. SmithFA.Factitious disorders and malingering. In: SternTA, RosenbaumJF, FavaM, et al., (Eds.). Massachusetts General Hospital Comprehensive Clinical Psychiatry. Philadelphia: Mosby Elsevier; 2008.
9. SchwartzP, WeathersM.The psychotic patient. In: RibaM, RavindranathD, (Eds.). Clinical Manual of Emergency Psychiatry. Washington, DC: American Psychiatric Publishing, Inc; 2010.
10. SimakhodskyayZ, HaddadF, QuinteroM, RavindranathD, GlickRL.Disposition and resource options. In: RibaM, RavindranathD, (Eds.). Clinical Manual of Emergency Psychiatry. Washington, DC: American Psychiatric Publishing, Inc; 2010.
11. LazarusA, KozinnWP.Munchausen’s syndrome with hematuria and sepsis: an unusual case. Int J Psychiatry Med 1991;21:113–16.
12. BretzSW, RichardsJR.Munchausen syndrome presenting acutely in the emergency department. J Emerg Med 2000;18:417–20.
13. HedgesBE, DimsdaleJE, HoytDB.Munchausen syndrome presenting as recurrent multiple trauma. Psychosomatics 1995;36:60–3.

References

1. SamarasN, ChevalleyT, SamarasD, GoldG. Older patients in the emergency department: a review. Ann Emerg Med 2010;56:261–9.
2. InouyeSK. Delirium in older persons. N Engl J Med 2006;354:1157–65.
3. TerrellKM, HusteyFM, HwangU, et al. Quality indicators for geriatric emergency care. Acad Emerg Med 2009;16:441–9.
4. MittalD, MajithiaD, KennedyR, RhudyJ. Differences in characteristics and outcome of delirium as based on referral patterns. Psychosomatics 2006;47:367–75.
5. KielyDK, MarcantonioER, InouyeSK, et al. Persistent delirium predicts greater mortality. J Am Geriatr Soc 2009;57:55–61.
6. BellelliG, FrisoniGB, TurcoR, et al. Delirium superimposed on dementia predicts 12-month survival in elderly patients discharged from a postacute rehabilitation facility. J Gerontol A Biol Sci Med Sci 2007;62:1306–9.
7. BreitbartW, GibsonC, TremblayA. The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 2002;43:183–94.
8. SchulzR, BeachSR. Caregiving as a risk factor for mortality: the Caregiver Health Effects Study. JAMA 1999;282:2215–19.
9. CohenCA, PushkarD. Lessons learned from a longitudinal study of dementia care. Am J Geriatr Psychiatry 1999;7:139–46.
10. SmithJSJ. Delirium and dementia. In: MarxJHR, WallsR, (Eds.). Rosen’s Emergency Medicine, (7th Edition). St. Louis: Mosby; 2009.
11. FongTG, TulebaevSR, InouyeSK. Delirium in elderly adults: diagnosis, prevention and treatment. Nat Rev Neurol 2009;5:210–20.
12. HanJH, ZimmermanEE, CutlerN, et al. Delirium in older emergency department patients: recognition, risk factors, and psychomotor subtypes. Acad Emerg Med 2009;16:193–200.
13. KakumaR, du FortGG, ArsenaultL, et al. Delirium in older emergency department patients discharged home: effect on survival. J Am Geriatr Soc 2003;51:443–50.
14. HusteyFM, MeldonSW, SmithMD, LexCK. The effect of mental status screening on the care of elderly emergency department patients. Ann Emerg Med 2003;41:678–84.
15. LeslieDL, MarcantonioER, ZhangY, Leo-SummersL, InouyeSK. One-year health care costs associated with delirium in the elderly population. Arch Intern Med 2008;168:27–32.
16. InouyeSK, RushingJT, ForemanMD, PalmerRM, PompeiP. Does delirium contribute to poor hospital outcomes? A three-site epidemiologic study. J Gen Intern Med 1998;13:234–42.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR (4th Edition). Arlington, VA: American Psychiatric Publishing, Inc.; 2000.
18. WilberST, LofgrenSD, MagerTG, BlandaM, GersonLW. An evaluation of two screening tools for cognitive impairment in older emergency department patients. Acad Emerg Med 2005;12:612–16.
19. WongCL, Holroyd-LeducJ, SimelDL, StrausSE. Does this patient have delirium?: value of bedside instruments. JAMA 2010;304:779–86.
20. CarpenterCR, DesPainB, KeelingTN, ShahM, RothenbergerM. The Six-Item Screener and AD8 for the detection of cognitive impairment in geriatric emergency department patients. Ann Emerg Med 2011;57:653–61.
21. WilberST, CarpenterCR, HusteyFM. The Six-Item Screener to detect cognitive impairment in older emergency department patients. Acad Emerg Med 2008;15:613–6.
22. ElieM, ColeMG, PrimeauFJ, BellavanceF. Delirium risk factors in elderly hospitalized patients. J Gen Intern Med 1998;13:204–12.
23. InouyeSK, CharpentierPA. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA 1996;275:852–7.
24. FrancisJ, MartinD, KapoorWN. A prospective study of delirium in hospitalized elderly. JAMA 1990;263:1097–101.
25. InouyeSK, BogardusST Jr, CharpentierPA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999;340:669–76.
26. TrzepaczPT, LeonardM. Delirium. In: LevensonJL, (Ed.). The American Psychiatric Publishing Textbook of Psychosomatic Medicine: Psychiatric Care of the Medically Ill, (2nd Edition). Arlington, VA: American Psychiatric Publishing, Inc; 2011: 71–114.
27. NatalwalaA, PotluriR, UppalH, HeunR. Reasons for hospital admissions in dementia patients in Birmingham, UK, during 2002–2007. Dement Geriatr Cogn Disord 2008;26:499–505.
28. NourhashemiF, AndrieuS, SastresN, et al. Descriptive analysis of emergency hospital admissions of patients with Alzheimer disease. Alzheimer Dis Assoc Disord 2001;15:21–5.
29. BrookmeyerR, CorradaMM, CurrieroFC, KawasC. Survival following a diagnosis of Alzheimer disease. Arch Neurol 2002;59:1764–7.
30. MeierDE, AhronheimJC, MorrisJ, Baskin-LyonsS, MorrisonRS. High short-term mortality in hospitalized patients with advanced dementia: lack of benefit of tube feeding. Arch Intern Med 2001;161:594–9.
31. MitchellSL, TenoJM, KielyDK, et al. The clinical course of advanced dementia. N Engl J Med 2009;361:1529–38.
32. LyketsosCG, SheppardJM, RabinsPV. Dementia in elderly persons in a general hospital. Am J Psychiatry 2000;157:704–7.
33. FuC, ChuteDJ, FaragES, et al. Comorbidity in dementia: an autopsy study. Arch Pathol Lab Med 2004;128:32–8.
34. HolsingerT, DeveauJ, BoustaniM, WilliamsJWJr. Does this patient have dementia?JAMA 2007;297:2391–404.
35. BlennowK, de LeonMJ, ZetterbergH. Alzheimer’s disease. Lancet 2006;368:387–403.
36. LoboASP, QuintanillaMA. Dementia. In: LevensonJL, (Ed.). The American Psychiatric Publishing Textbook of Psychosomatic Medicine: Psychiatric Care of the Medically Ill, (2nd Edition). Arlington, VA: American Psychiatric Publishing, Inc; 2011: 115–51.
37. LyketsosCG, LopezO, JonesB, et al. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002;288:1475–83.
38. RopackiSA, JesteDV. Epidemiology of and risk factors for psychosis of Alzheimer’s disease: a review of 55 studies published from 1990 to 2003. Am J Psychiatry 2005;162:2022–30.
39. National Institute of Neurological Disorders and Stroke. NINDS Dementia With Lewy Bodies Information Page. Available at: http://www.ninds.nih.gov/disorders/dementiawithlewybodies/dementiawithlewybodies.htm (Accessed December 28, 2011).
40. American Psychiatric Association. Practice guideline for the treatment of patients with Alzheimer’s disease and other dementias, second edition. Am J Psychiatry 2007;164:5–56.
41. U.S. Food and Drug Administration. Public Health Advisory: Deaths with Antipsychotics in Elderly Patients with Behavioral Disturbances. Available at: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHealthcareProfessionals/PublicHealthAdvisories/ucm053171.htm.
42. U.S. Food and Drug Administration. FDA Requests Boxed Warnings on Older Class of Antipsychotic Drugs 2008. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116912.htm.

References

1. ACEP Excited Delirium Task Force. White Paper Report on Excited Delirium Syndrome. 2009. Available at: http://ccpicd.com/Documents/Excited%20Delirium%20Task%20Force.pdf (Accessed June 7, 2011).
2. HallC, ButlerC, KaderA, et al. Police use of force, injuries and death: prospective evaluation of outcomes for all police use of force/restraint including conducted energy weapons in a large Canadian city. Acad Emerg Med 2009;16:S198–9.
3. Excited Delirium. Education, Research, and Information. Available at: http://www.exciteddelirium.org (Accessed January 28, 2012).
4. Madness.in.the.fast.lane. Available at: http://www.youtube.com/watch?v=e5oFVHE1-Ko (Accessed January 18, 2012).
5. StrattonSJ, RogersC, BrickettK, GruzinskiG.Factors associated with sudden death of individuals requiring restraint for excited delirium. Am J Emerg Med 2001;19:187–91.
6. BellL.On a form of disease resembling some advanced stages of mania and fever, but so contradistinguished from any ordinarily observed or described combination of symptoms, as to render it probable that it may be an overlooked and hitherto unrecorded malady. Am J Insanity 1849;6:97–127.
7. KrainesSH.Bell’s Mania. Am J Psychiatry 1934;91:29–40.
8. WetliCV, FishbainDA.Cocaine-induced psychosis and sudden death in recreational cocaine users. J Forensic Sci 1985;30:873–80.
9. ReayDT, FlignerCL, StilwellAD, et al. Positional asphyxia during law enforcement transport. Am J Forensic Med Pathol 1992;13:90–7.
10. O’HalloranRL, LewmanLV. Restraint asphyxiation in excited delirium. Am J Forensic Med Pathol 1993;14:289–95.
11. StephensBG, JentzenJM, KarchS, WetliCV, MashDC.National Association of Medical Examiners position paper on the certification of cocaine-related deaths. Am J Forens Med Sci 2004;25:11–13.
12. DiMaioTG, DiMaioVJM.Excited Delirium Syndrome Cause of Death and Prevention, (1st Edition). Boca Raton, FL: Taylor & Francis Group; 2006: 1–60.
13. GrantJR, SouthallPE, MealeyJ, ScottSR, FowlerDR.Excited delirium deaths in custody past and present. Am J Forensic Med Pathol 2009;30:1–5.
14. OtahbuchiM, CevikC, BagdureS, NugentK.Excited delirium, restraints, and unexpected death: a review of pathogenesis. Am J Forensic Med Pathol 2010;31:1–6.
15. TakeuchiA, AhernTL, HendersonSO.Excited delirium. West J Emerg Med 2011;12:77–83.
16. VilkeGM, DeBardML, ChanTC, et al. Excited Delirium Syndrome (ExDS): defining based on a review of the literature. J Emerg Med 2011 [Epub ahead of print].
17. VilkeGM, Payne-JamesJ, KarschSB.Excited Delirium Syndrome (ExDS): redefining an old diagnosis. J Forens Legal Med 2012;19:7–11.
18. VilkeGM, BozemanWP, DawesDM, DeMersG, WilsonMP.Excited delirium syndrome (ExDS): treatment options and considerations. J Forensic Leg Med 2012;19:117–21.
19. VilkeGM, WilsonMP.Agitation: what every emergency physician should know. Emerg Med Rep 2009;30:1–8.
20. EscobedoLG, RuttenberAJ, AgocsMM, AndaRF, WetliCV.Emerging patterns of cocaine use and the epidemic of cocaine overdose deaths in Dade County, Florida. Arch Pathol Lab Med 1991;115:900–5.
21. RuttenberAJ, SweeneyPA, MendleinJM, WetliCV.Preliminary findings of an epidemiologic study of cocaine-related deaths, Dade County, Florida, 1978–85. NIDA Res Monogr 1991;110:95–112.
22. MirchandaniHG, RorkeLB, Sekula-PerlmanA, HoodIC.Cocaine-induced agitated delirium, forceful struggle, and minor head injury: a further definition of sudden death during restraint. Am J Forensic Med Pathol 1994;15:95–9.
23. WetliCV.MashD, KarchSB.Cocaine-associated agitated delirium and the neuroleptic malignant syndrome. Am J Emerg Med 1996;14:425–8.
24. HickJL, SmithSW, LynchMT.Metabolic acidosis in restraint-associated cardiac arrest: a case series. Acad Emerg Med 1999;6:239–43.
25. RuttenberAJ, McAnallyHB, WetliCV.Cocaine-associated rhabdomyolysis and excited delirium: different stages of the same syndrome. Am J Forensic Med Pathol 1999;20:120–7.
26. AllamS, NobleJS.Cocaine-excited delirium and severe acidosis. Anesthesia 2001;56:385–6.
27. GruszeckiAC, McGwinG, RobinsonA, DavisGG.Unexplained sudden death and the likelihood of drug abuse. J Forensic Sci 2005;50:1–4.
28. BunaiY, AkazaK, JiangWX, NagaiA.Fatal hyperthermia associated with excited delirium during an arrest. Leg Med (Tokyo) 2008;10:306–9.
29. MashDC, DuqueL, Pablo J, et al. Brain biomarkers for identifying excited delirium as a cause of sudden death. Forensic Sci Int 2009;190:e13–19.
30. MashDC. Biochemical brain markers in excited delirium deaths. In: KrollMW, HoJD, (Eds.). TASER Conducted Electrical Weapons: Physiology, Pathology, and Law. New York, NY: Springer; 2009: 365–77.
31. RichmondJS, BerlinJS, FishkindA, et al. Verbal de-escalation of the agitated patient: consensus statement of the American Association for Emergency Psychiatry Project BETA De-escalation Workgroup. West J Emerg Med 2012;13:17–25.
32. WilsonMP, ZellerSL.Introduction: reconsidering psychiatry in the emergency department. J Emerg Med [Epub ahead of print].
33. WilsonMP, SloaneC.Chemical restraints, physical restraints, and other demonstrations of force. In: JesusJ, (Ed.). Ethical Problems in the Emergency Department. New York: Wiley-Blackwell; [In press].
34. HoJD, DawesDM, NelsonRS, et al. Acidosis and catecholamine evaluation following simulated law enforcement “Use of force” encounters. Acad Emerg Med 2010;12:E60–6.
35. HoJD, DawesDM, ColeJB, et al. Lactate and pH evaluation in exhausted humans with prolonged TASER® X26 exposure or continued exertion. Forensic Sci Int 2009;190:80–6.
36. HoJD, DawesDM, BultmanLL, et al. Prolonged TASER® use on exhausted humans does not worsen markers of acidosis. Am J Emerg Med 2009;27:413–18.
37. NordstromK, ZunLS, WilsonMP, et al. Medical evaluation and triage of the agitated patient: consensus statement of the American Association for Emergency Psychiatry Project BETA Medical Evaluation Workgroup. West J Emerg Med 2012;13:3–10.
38. WilsonMP, PepperD, CurrierGW, HollomanGH, FeifelD.The psychopharmacology of agitation: consensus statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup. West J Emerg Med 2012;13:26–34.
39. RichardsJR, SchneirAB.Droperidol in the emergency department: is it safe?J Emerg Med 2001;24:441–7.
40. ZellerSL, RhoadesR.Systematic reviews of assessment measures and pharmacologic treatments for agitation. Clin Ther 2010;32:403–25.
41. CitromeL.Comparison of intramuscular ziprasidone, olanzapine, or aripiprazole for agitation: a quantitative review of efficacy and safety. J Clin Psychiatry 2007;68:1876–85.
42. WilsonMP, MacDonaldK, VilkeGM, RonquilloL, FeifelD.Use of Intramuscular Ziprasidone by ED Clinicians and its Effect on Vital Signs. National Behavioral Emergencies Conference, December 1–2, 2011; Las Vegas, Nevada.
43. WilsonMP, MacDonaldKS, VilkeGM, FeifelD.A comparison of the safety of olanzapine and haloperidol in combination with benzodiazepines in emergency department patients with acute agitation. J Emerg Med 2011 [Epub ahead of print].
44. WilsonMP, MacDonaldKS, VilkeGM, FeifelD.Potential complications of combining intramuscular olanzapine with benzodiazepines in agitated emergency department patients. J Emerg Med 2010 [Epub ahead of print].
45. MacdonaldK, WilsonMP, MinassianA, et al. A retrospective analysis of intramuscular haloperidol and intramuscular olanzapine in the treatment of agitation in drug- and alcohol-using patients. Gen Hosp Psychiatry 2010;32:443–5.
46. ZellerSL, WilsonMP.Acute treatment of agitation in schizophrenia. Drug Discov Today Ther Strateg 2011;8:25–9.
47. GreenSM, RobackMG, KennedyRM, et al. Clinical practice guideline for emergency department ketamine dissociative sedation: 2011 Update. Ann Emerg Med 2010;57:449–61.
48. BurnettAM, WattersBJ, BarringerKW, et al. Laryngospasm and hypoxia after intramuscular administration of ketamine to a patient in excited delirium. Prehosp Emerg Care 2012;16:412–14.
49. RobertsJR, GeetingGK.Intramuscular ketamine for the rapid tranquilization of the uncontrollable, violent, and dangerous adult patient. J Trauma 2001;51:1008–10.
50. HickJL, HoJD.Ketamine chemical restraint to facilitate rescue of a combative “jumper”. Prehosp Emerg Care 2005;9:85–9.
51. BattagliaJ, MossS, RushJ, et al. Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study. Am J Emerg Med 1997;15:335–40.

References

1. AlegriaM, JacksonJS, KesslerRC, TakeuchiD. Collaborative Psychiatric Epidemiology Surveys, 2001–2003. Ann Arbor, MI: Institute for Social Research, Survey Research Center; 2007.
2. KroenkeK, SpitzerRL, JanetBW, WilliamsDSW. Physical symptoms in primary care: predictors of psychiatric disorders and functional impairment. Arch Fam Med 1994;3:774–9.
3. LipowskiZL. The interface of psychiatry and medicine: towards integrated health care. Can J Psychiatry 1987;32:743–8.
4. CurranGM, SullivanG, WilliamsK, et al. Emergency department use of persons with comorbid psychiatric and substance abuse disorders. Ann Emerg Med 2003;41:659–67.
5. SchrigerDL, GibbonsPS, LangoneCA, et al. Enabling the diagnosis of occult psychiatric illness in the emergency department: a randomized, controlled trial of the computerized, self-administered PRIME-MD. Ann Emerg Med 2001;37:132–40.
6. SantucciKA, SatherJ, BakerMD. Emergency medicine training programs’ educational requirements in the management of psychiatric emergencies: current perspective. Pediatr Emerg Care 2003;19:154–6.
7. BillingsJ, ParikhN, MijanovichT. Emergency department use in New York City: a substitute for primary care?Issue Brief (Commonw Fund) 2000;433:1–5.
8. Mental Illness Accounts for Large Portion of ED. Psychiatric News, August 20, 2010.
9. RhodesKV, ViethTL, KushnerH, et al. Referral without access: for psychiatric services, wait for the beep. Ann Emerg Med 2009;54:272–8.
10. FelkerB, YazelJJ, ShortD. Mortality and medical comorbidity among psychiatric patients: a review. Psychiatr Serv 1996;47:1356–63.
11. MykletunA, BjerkesetO, OverlandS, et al. Levels of anxiety and depression as predictors of mortality: the HUNT Study. Br J Psychiatry 2009;195:118–25.
12. GlassmanAH, BiggerT, GaffneyM. Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression. Arch Gen Psychiatry 2009;66:1022–9.
13. PanA, SunQ, OkerekeO, et al. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA 2011;306:1241–9.
14. KesslerRC. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry 1996;66:17–31.
15. LasserK, BoydJW, WoolhandlerS, et al. Smoking and mental illness-a population-based prevalence study. JAMA 2000;284:2606–10.
16. DarreA, RegierMD, FarmerME, et al. Comorbidity of mental disorders with alcohol and other drug abuse results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511–18.
17. ScottD, HappellB. The high prevalence of poor physical health and unhealthy lifestyle behaviours in individuals with severe mental illness. Issues Ment Health Nurs 2011;32:589–97.
18. NewcomerJW, HauptDW. The metabolic effects of antipsychotic medications. Can J Psychiatry 2006;51:480.
19. CorinneMH, DankoffJ, ColaconeA, et al. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emer Med 2001;38:666–71.
20. HowardM, DolovichL, KaczorowskiL, et al. Prescribing of potentially inappropriate medications to elderly people. Fam Pract 2004;21:244–7.
21. McNicollL, PisaniMA, ZhangY, et al. Delirium in the intensive care unit. J Am Geriatr Soc 2003;51:591–8.
22. HusteyFM, MeldonSW. The prevalence and documentation of impaired mental status in elderly emergency department patients. Ann Emerg Med 2002;39:248–53.
23. ElieM, RousseauF. Prevalence and detection of delirium in elderly emergency department patients. Can Med Assoc J 2000;163:977–81.
24. KesslerRC, BerglundP, DemlerO, et al. The epidemiology of major depressive disorder: results from the National Comorbidity survey replication. JAMA 2003;289:3095–105.
25. ClaassenCA, LarkinGL. Occult suicidality in an emergency department population. Br J Psychiatry 2005;186:352–3.
26. SchwabJJ, ClemmonsRS, BialowM, et al. The affective symptomatology of depression in medical inpatients. Psychosomatics 1966;7:214–17.
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, (4th Edition) Text Revision. Arlington, VA: American Psychiatric Association; 2000.
28. EndicottJ. Measurement of depression in patients with cancer. Cancer 1984;53:2243–8.
29. AkechiT, IetsuguT, SukigaraM, et al. Symptom indicator of severity of depression in cancer patients: a comparison of the DSM-IV criteria with alternative diagnostic criteria. Hosp Psychiatry 2009;31:225–32.
30. NgTP, NitiM, TanWC, et al. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007;167:6–7.
31. AbramsTE, SarrazinMV, VanderWegMW. Acute exacerbations of chronic obstructive pulmonary disease and the effect of existing psychiatric comorbidity on subsequent mortality. Psychosomatics 2011;52:441–9.
32. ShapiroPA, LidogosterL, GlassmanAH. Depression and heart disease. Psychiatr Ann 1997;27:347–52.
33. Frasure-SmithN, LespéranceF, TalajicM. Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993;270:1819–25.
34. BerkmanLF, BlumenthalJ, BurgM, et al. Enhancing Recovery in Coronary Heart Disease (ENRICHD). JAMA 2003;289:3106–16.
35. FleetRP, DupuisG, MarchandA, et al. Panic disorder in emergency department chest pain patients: prevalence, comorbidity, suicidal ideation, and physician recognition. Am J Med 1996;101:371–80.
36. CraigTKJ. In: BrownGW, (Ed.). Abdominal Pain, in Life Events and Illness. New York: Guilford; 1989: 233–59.
37. GuthrieE, JacksonJ, ShafferJ, et al. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn’s disease. Am J Gastroenterol 2002;97:1994–9.
38. JacksonJL, OMalleyPG, TomkinsG, et al. Treatment of functional GI disorders with antidepressant medications. Am J Med 2000;108:65–72.
39. HanleyO, MinerJ, RockswoldE, BirosM. The relationship between chronic illness, chronic pain and socioeconomic factors in the ED. Am J Emerg Med 2011;29:266–93.
40. SimonGE, VonKorffM, PiccinelliM, et al. An international study of the relation between somatic symptoms and depression. N Engl J Med 1999;341:1329–35.

References

1. HarrisE, BarracloughB.Excess mortality of mental disorder. Br J Psychiatry 1998;173:11–53.
2. Chamay-WeberC, NarringF, MichaudP.Partial eating disorders among adolescents: a review. J Adolesc Health 2005;37:417–27.
3. FairburnC, CooperZ, DollH, NormanP, O’ConnorM.The natural course of bulimia nervosa and binge eating disorder in young women. Arch Gen Psychiatry 2000;57:659–65.
4. HautalaL, JunnilaJ, AlinJ, et al. Uncovering hidden eating disorders using the SCOFF questionnaire: cross-sectional survey of adolescents and comparison with nurse assessments. Int J Nurs Stud 2009;46:1439–47.
5. JohnstonO, FornaiG, CabriniS, KendrickT.Feasibility and acceptability of screening for eating disorders in primary care. Fam Pract 2007;24:511–17.
6. MondJ, MyersT, CrosbyR, et al. Screening for eating disorders in primary care: EDE-Q versus SCOFF. Behav Res Ther 2008;46:612–22.
7. OggE, MillarH, PusztaiE, ThomA.General practice consultation patterns preceding diagnosis of eating disorders. Int J Eat Disord 1997;22:89–93.
8. Striegel-MooreR, DohmF, KraemerH, et al. Health services use in women with a history of bulimia nervosa or binge eating disorder. Int J Eat Disord 2005;37:11–18.
9. CrowS, PrausB, ThurasP.Mortality from eating disorders – a 5- to 10-year record linkage study. Int J Eat Disord 1999;26:97–101.
10. BirminghamC, SuJ, HlynskyJ, GoldnerE, GaoM.The mortality rate from anorexia nervosa. Int J Eat Disord 2005;38:143–6.
11. FichterM, QuadfliegN, HedlundS.Twelve-year course and outcome predictors of anorexia nervosa. Int J Eat Disord 2006;39:87–100.
12. HoekH.Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. Curr Opin Psychiatry 2006;19:389–94.
13. KeelP, DorerD, EddyK, et al. Predictors of mortality in eating disorders. Arch Gen Psychiatry 2003;60:179–83.
14. PompiliM, GirardiP, TatarelliG, RubertoA, TatarelliR.Suicide and attempted suicide in eating disorders, obesity and weight-image concern. Eat Behav 2006;7:384–94.
15. CrowS, PetersonC, SwansonS, et al. Increased mortality in bulimia nervosa and other eating disorders. Am J Psychiatry 2009;AiA:1–5.
16. FrankoD, KeelP, DorerD, et al. What predicts suicide attempts in women with eating disorders?Psychol Med 2004;34:843–53.
17. AgrasW, editor. The Oxford Handbook of Eating Disorders, (1st Edition). New York, NY: Oxford University Press; 2010.
18. American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders, (4th Edition). Waltham, MA: American Psychiatric Association; 1994.
19. Striegel-MooreR, WonderlichS, WalshB, MitchellJ, (Eds.). Developing an Evidence-Based Classification of Eating Disorders. Scientific Findings for DSM-V, (1st Edition). Arlington, VA: American Psychiatric Association; 2011.
20. KeelP, HeathertonT, DorerD, JoinerT, ZaltaA.Point prevalence of bulimia nervosa in 1982, 1992, and 2002. Psychol Med 2006;36:119–27.
21. American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, (4th Edition). Waltham, MA: American Psychiatric Association; 2000.
22. CrowtherJ, ArmeyM, LuceK, DaltonG, LeaheyT.The point prevalence of bulimic disorders from 1990 to 2004. Int J Eat Disord 2008;41:491–7.
23. FavaroA, FerraraS, SantanastasoP.The spectrum of eating disorders in young women: a prevalence study in a general population sample. Psychosom Med 2003;65:701–8.
24. WadeT, BerginJ, TiggermannM, BulikC, FairburnC.Prevalence and long-term course of lifetime eating disorders in an adult Australian twin cohort. Aust N Z J Psychiatry 2006;40:121–8.
25. HudsonJI, HiripiE, PopeHG Jr, KesslerRC.The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007;61:348–58.
26. Domine’F, BerchtoldA, Akre’C, MichaudP, SurisJ.Disordered eating behaviors: what about boys?J Adolesc Health 2009;44:111–17.
27. ShawH, RamirezL, TrostA, RandallP, SticeE.Body image and eating disturbances across ethnic groups: more similarities than differences. Psychol Addict Behav 2004;18:12–18.
28. Young-HymanD, DavisC.Disordered eating behavior in individuals with diabetes: importance of context, evaluation and classification. Diabetes Care 2010;33:683–9.
29. SegalA, Kinoshita KussunokiD, LarinoM.Post-surgical refusal to eat: anorexia nervosa, bulimia nervosa or a new eating disorder? A case series. Obes Surg 2004;14:353–60.
30. KatzmanD.Medical complications in adolescents with anorexia nervosa: a review of the literature. Int J Eat Disord 2005;37(Suppl):S52–9.
31. NudelD, GootmanN, NussbaumM, ShenkerI.Altered exercise performance and abnormal sympathetic responses to exercise in patients with anorexia nervosa. J Pediatr 1984;105:34–7.
32. PanagiotopoulosC, McCrindleB, HickK, KatzmanD.Electrocardiographic findings in patients with eating disorders. Pediatrics 2000;105:1100–5.
33. MehlerP, AndersonA.Eating Disorders: a Guide to Medical Care and Complications, (2nd Edition). Baltimore, MD: The Johns Hopkins University Press; 2010.
34. SwenneI, LarssonP.Heart risk associated with weight loss in anorexia nervosa and eating disorders: risk factors for QTc prolongation and dispersion. Acta Paediatr 1999;88:304–9.
35. MontL, CastroJ, HerrerosB, et al. Reversibility of cardiac abnormalities in adolescents with anorexia nervosa after weight recovery. J Am Acad Child Adolesc Psychiatry 2003;42:808–13.
36. SilberT.Ipecac syrup abuse, morbidity, and mortality: isn’t it time to repeal its over-the-counter status?J Adolesc Health 2005;37:256–60.
37. PomeroyC, MitchellJ.Medical complications of anorexia nervosa and bulimia nervosa. In: Fairburn CG, Brownell UD (Eds), Eating Disorders and Obesity: A Comprehensive Handbook, (2nd Edition). New York: Guilford Press; 2002: 278–85.
38. ChenK, ChenJ, KuoS, et al. Descending necrotizing mediastinitis: a 10-year surgical experience in a single institution. J Thor Cardiov Surg 2008;136:191–8.
39. ZipfelS, SammetI, RappsN, et al. Gastrointestinal disturbances in eating disorders: clinical and neurobiological causes. Auton Neurosci 2006;129:99–106.
40. MitchellJ, CrowS.Medical complications of anorexia nervosa and bulimia nervosa. Curr Opin Psychiatry 2006;19:438–43.
41. MitchellJ, PomeroyC, SeppalaM.Pseudo-Bartter’s Syndrome, diuretic abuse and eating disorders. Int J Eat Disord 1988;7:225–37.
42. MattinglyD, BhanjiS.Hypoglycaemia and anorexia nervosa. J R Soc Med 1995;88:191–5.
43. Goebel-FabbriA.Disturbed eating behaviors and eating disorders in type 1 diabetes: clinical significance and treatment recommendations. Curr Diab Rep 2009;9:133–9.
44. LaskB, GordonI, ChristieD, et al. Functional neuroimaging in early onset anorexia nervosa. Int J Eat Disord 2005;37:S49.
45. BogleK, SmithB.Illicit methylphenidate use: a review of prevalence, availability, pharmacology, and consequences. Curr Drug Abuse Rev 2009;2:157–76.
46. PiranN, RobinsonS.Associations between disordered eating behaviors and licit and illicit substance use and abuse in a university sample. Addict Behav 2006;31:1761–75.
47. GoldenN, KatzmanD, KreipeR, et al. Eating disorders in adolescents: position paper of the society for adolescent medicine. J Adolesc Health 2003;33:496–503.
48. SteinhausenH.The outcome of anorexia nervosa in the 20th century. Am J Psychiatry 2002;159:1284–93.
49. HillL, ReidF, MorganJ, LaceyJ.SCOFF, the development of an eating disorder screening questionnaire. Int J Eat Disord 2010;43:344–51.

References

1. U.S. Department of Health and Human Services. About Co-occurring. Substance Abuse and Mental Health Services Administration Newsletter. U.S. Department of Health and Human Services. Available at: http://www.samhsa.gov/co-occurring/ (Accessed December 22, 2011).
2. KesslerRC, NelsonCB, McGonagleKA, et al. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Addict 1996;66:17–31.
3. RegierDA, FarmerME, RaeDS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511–18.
4. DrakeRE, MueserKT.Co–Occurring Alcohol Use Disorder and Schizophrenia. National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, November 2002. Available at: http://pubs.niaaa.nih.gov/publications/arh26-2/99-102.htm
5. SayersSL, CampbellEC, KondrichJ, et al. Cocaine abuse in schizophrenic patients treated with olanzapine versus haloperidol. J Nerv Ment Dis 2005;193:379–86.
6. ClarkRE, SamnalievM, McGovernMP.Treatment for co-occurring mental and substance use disorders in five state Medicaid programs. Psychiat Serv 2007;58:942–8.
7. SimmonsLA, HavensJR.Comorbid substance and mental disorders among rural Americans: results from the national comorbid survey. J Affect Disord 2007;99:265–71.
8. MericleAA, Ta ParkVM, HolckP, ArriaAM.Prevalence, patterns, and correlates of co-occurring substance use and mental disorders in the United States: variations by race/ethnicity. Compr Psychiatry 2011 [Epub ahead of print].
9. RobertsA.Psychiatric comorbidity in white and African-American illicit substance abusers: evidence for differential etiology. Clin Psychol Rev 2011;20:667–77.
10. Center for Substance Abuse Treatment. Substance Abuse Treatment for Persons With Co-Occurring Disorders. Treatment Improvement Protocol (TIP) Series 42. DHHS Publication No. (SMA) 05-3922. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2005. Available at: http://www.ncbi.nlm.nih.gov/books/NBK25700/.
11. LeeMO, VivierPM, DiercksDB.Is the self-report of recent cocaine or methamphetamine use reliable in illicit stimulant drug users who present to the Emergency Department with chest pain? J Emerg Med 2009;37:237–41.
12. SkinnerHA.The drug abuse screening test. Addict Behav 1982;7:363–71.
13. GavinDR, RossHE, SkinnerHA.Diagnostic validity of the Drug Abuse Screening Test in the assessment of DSM-III drug disorders. Br J Addict 1989;84:301–7.
14. KellermanA, FihnSD, LoGerfoJP, CopassMK.Impact of drug screening in suspected overdose. Ann Emerg Med 1987;16:1206–16.
15. PerroneJ, De RoosF, JayaramanS, HollanderJE.Drug screening versus history in detection of substance use in ED psychiatric patients. Am J Emerg Med 2001;19:49–51.
16. OwensPL, MutterR, StocksC.Mental Health and Substance Abuse-related Emergency Department Visits, 2007. AHRQ Statistical Brief #92, July 2010. Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb92.pdf.
17. CatonCL, HasinDS, ShroutPE, et al. Stability of early-phase primary psychotic disorders with concurrent substance use and substance-induced psychosis. Br J Psychiatry 2007;190:105–11.
18. RiesRK, Yuodelis-FloresC, ComtoisKA, Roy-ByrnePP, RussoJE.Substance-induced suicidal admissions to an acute psychiatric service: characteristics and outcomes. J Subst Abuse Treat 2008;34:72–9.
19. KingCA, O’MaraRM, HaywardCN, CunninghamRM.Adolescent suicide risk screening in the emergency department. Acad Emerg Med 2009;16:234–41.
20. Esposito-SmythersC, SpiritoA, KahlerCW, HuntJ, MontiP.Treatment of co-occurring substance abuse and suicidality among adolescents: a randomized trial. J Consult Clin Psychol 2011;79:728–39.
21. PagesKP, RussonJE, WingersonDK, et al. Predictors and outcome of discharge against medical advice from the psychiatric units of a general hospital. Psychiat Serv 1998;49:1187–92.
22. DingK, YangJ, ChengG, et al. Hospitalizations and hospital charges for co-occurring substance use and mental disorders. J Subst Abuse Treat 2011;40:366–75.
23. SmelsonDA, ZiedonisD, WilliamsJ, et al. The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report. J Clin Psychopharmacol 2006;26:9–12.
24. PettinatiHM, OslinDW, KampmanKM, et al. A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. Am J Psychiatry 2010;167:668–75.
25. SalloumIM, CorneliusJR, DaleyDC, et al. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry 2005;62:37–45.
26. ClearyM, HuntG, MathesonS, SiegfriedN, WalterG.Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev 2008;1:CD001088.
27. Agency for Healthcare Research and Quality. Detoxification and Substance Abuse Treatment: Co-occurring Medical and Psychiatric Conditions. National Guideline Clearinghouse. Agency for Healthcare Research and Quality. December 2011. Available at: http://www.ngc.gov/content.aspx?id=9119.